Neoadjuvant docetaxel and capecitabine in patients with high risk prostate cancer - Comment Journal Article
| Author: | Morris, M. J. |
| Article Title: | Neoadjuvant docetaxel and capecitabine in patients with high risk prostate cancer - Comment |
| Keywords: | treatment response; fluorouracil; capecitabine; adjuvant therapy; metastasis; antineoplastic activity; docetaxel; prostate cancer; drug metabolism; drug dose regimen; thymidine phosphorylase; micrometastatic disease |
| Journal Title: | Journal of Urology |
| Volume: | 179 |
| Issue: | 3 |
| ISSN: | 0022-5347 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2008-03-01 |
| Start Page: | 915 |
| End Page: | 916 |
| Language: | English |
| DOI: | 10.1016/j.juro.2007.10.156 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Export Date: 17 November 2011" - "CODEN: JOURA" - "Source: Scopus" |
